What You Should Know:
- Jimini Health, a digital health company reimagining mental healthcare, has announced its launch with $8 million in pre-seed funding from Zetta Venture Partners, LionBird, PsyMed, BoxGroup, Arkitekt Ventures, SCB, and others.
- The company offers a unique, clinician-led therapy model enhanced by responsible AI, aiming to improve patient outcomes and transform the mental health experience.
- Jimini Health was co-founded by Luis Voloch, Mark Jacobstein,
Read More
The Clinic by Cleveland Clinic Appoints Dr. David Peter as Chief Medical Officer
What You Should Know:
- The Clinic by Cleveland Clinic, a provider of virtual second opinions (VSOs), has appointed Dr. David Peter as its new Chief Medical Officer (CMO).
- Dr. Peter brings a wealth of experience in clinical excellence, executive leadership, and care transformation to this role, where he will guide The Clinic's continued growth and expansion of high-quality specialty care access across the United States.
Dr. Peter Bio/Background
Dr. Peter most recently
Read More
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Lunit, AstraZeneca Partner to Develop AI-Powered Pathology Tools for Faster Lung Cancer Diagnostics
What You Should Know:
- Lunit, a provider of AI solutions for cancer diagnostics and therapeutics, has announced a strategic collaboration with AstraZeneca, a global pharmaceutical company, to develop AI-powered digital pathology solutions.
- The partnership aims to improve cancer treatment by leveraging AI to analyze tissue samples and predict the likelihood of specific genetic mutations.
Focusing on Lung Cancer Treatment with AI
The collaboration will initially focus on
Read More
NVIDIA BioNeMo Framework Accelerates AI Drug Discovery
What You Should Know:
- NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
- The framework provides a powerful suite of tools for scaling AI models in biomolecular research, bringing supercomputing capabilities to the forefront of drug development.
Accelerating Drug Discovery with AI
The BioNeMo Framework addresses the growing need
Read More
Report: Gen Z Leaving Healthcare in Droves Due to Toxic Culture
What You Should Know:
- A new report from Soliant Health reveals a concerning trend: healthcare professionals across all age groups are leaving the industry due to job stress, poor work-life balance, and unhealthy workplace cultures.
- Surprisingly, Gen Z (ages 18-27) is leading the exodus, with over 22% planning to leave their healthcare jobs within the next 1-3 years.
Generational Differences in Departure Drivers
While all generations struggle with workplace challenges,
Read More
Ransomware Attacks on Healthcare Services Surge in 2024
What You Should Know:
- Ransomware attacks are a growing threat across all industries, but the healthcare sector is facing a particularly alarming surge in these incidents, according to new data from SafetyDevices.
- New data reveals a concerning trend of increased attacks on healthcare providers, raising concerns about patient safety, data security, and the financial stability of healthcare organizations.
Healthcare: A Prime Target for Cybercriminals
Healthcare services are
Read More
Impilo Secures $11.5M to Expand Access to At-Home Healthcare
What You Should Know:
- Impilo, a digital health platform revolutionizing healthcare access raises $11.5M in a Series A funding round led by Construct Capital, with participation from GC 1 Capital, One Way Ventures, 2048 Ventures, and strategic angel investors.
- Impilo's vision is a world where access to world-class healthcare is no longer limited by location or circumstance. By leveraging technology and innovation, Impilo is making this vision a reality, bringing convenient,
Read More
Navigating the Complexities of Preclinical and Clinical Trials
The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which are vital for transitioning from laboratory research to clinical application. Let us take a look at the whole process – step by step.
Preclinical Studies: Laying the Groundwork
The preclinical phase involves extensive in vitro (test tube or cell culture) and
Read More
Q/A: Funding Landscape: IPO or Buyout for Life Science Companies?
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth, or is a strategic buyout from a larger company a more suitable path?
In this exclusive interview, Taylor Wirth, a partner at Barnes & Thornburg, offers his insights on evaluating market conditions, assessing company readiness, and weighing the pros and cons of each funding option. He
Read More
